Investment
Features
FeesSafety
Academy
More
Pluang+

Five Star Bancorp declares $0.25 per share cash dividend for Q2, payable August 10, 2026.

Company Fundamentals
17 Jul 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Five Star Bancorp announced a cash dividend of $0.25 per share on its common stock for the second quarter of 2026. The dividend will be paid on August 10, 2026, to shareholders recorded as of August 3, 2026. This move reflects the company's ongoing commitment to returning value to its shareholders. Five Star Bancorp operates through its wholly owned subsidiary, Five Star Bank, which recently expanded by opening a new branch in Lodi, California.

More News

Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics gets 'Outperform' rating on strong drug pipeline and FDA NDA acceptance for narcolepsy drug.

Axsome Therapeutics received an "Outperform" rating from BMO Capital due to significant progress in its drug pipeline, including FDA acceptance of its NDA for AXS-12, a narcolepsy treatment with a PDUFA date set for May 1, 2027. The company is also a...

Analyst Insights
Bullish
2 hours ago
Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.

Novartis is set to report its Q2 earnings with analysts expecting an EPS of $2.17 and revenue of $14.07 billion, following a tough Q1 affected by major patent expirations. Despite revenue challenges, the company maintained strong cash flow of $3.30 b...

Company Fundamentals
Neutral
2 hours ago
KeyCorp expects 20% EPS growth driven by strong loan demand and rising net interest income.

KeyCorp expects 20% EPS growth driven by strong loan demand and rising net interest income.

KeyCorp is set to report earnings with analysts forecasting a 20% increase in earnings per share to $0.42 and an 8% rise in total revenue to $1.97 billion. The growth is mainly driven by a 10% increase in net interest income, fueled by strong commerc...

Company Fundamentals
Bullish
3 hours ago
Biotech and manufacturing stocks plunge after major company shifts and financial concerns.

Biotech and manufacturing stocks plunge after major company shifts and financial concerns.

Several biotech and manufacturing companies saw significant stock declines due to key corporate events. Vision Marine Technologies dropped nearly 24% after shifting its focus from boat manufacturing to a mining project, causing investor uncertainty. ...

Market News
Bearish
3 hours ago
Biotech, AI, and leveraged ETFs soar on corporate events and strong business updates

Biotech, AI, and leveraged ETFs soar on corporate events and strong business updates

Shares of Zhengye Biotechnology surged over 1047% to regain Nasdaq compliance after a minimum bid price warning. Advanced Biomed and Axe Compute also saw notable gains following a reverse stock split and Russell Microcap Index inclusion, respectively...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App